Items where authors include "Lin, C-Y"
Up a levelArticle
Chu, T-Y, Zheng-Gérard, C, Huang, K-Y et al. (21 more authors) (2022) GPR97 triggers inflammatory processes in human neutrophils via a macromolecular complex upstream of PAR2 activation. Nature Communications, 13 (1). 6385. ISSN 2041-1723
Abbott, R, Abe, H, Acernese, F et al. (1664 more authors) (2022) Search for gravitational waves from Scorpius X-1 with a hidden Markov model in O3 LIGO data. Physical Review D, 106 (6). 062002. ISSN 2470-0010
Abbott, R, Abe, H, Acernese, F et al. (1693 more authors) (2022) Searches for gravitational waves from known pulsars at two harmonics in the second and third LIGO-Virgo observing runs. The Astrophysical Journal, 935 (1). 1. ISSN 0004-637X
Abbott, R, Abbott, TD, Acernese, F et al. (1656 more authors) (2022) Narrowband searches for continuous and long-duration transient gravitational waves from known pulsars in the LIGO-Virgo third observing run. The Astrophysical Journal, 932 (2). 133. ISSN 0004-637X
Abbott, R, Abbott, TD, Acernese, F et al. (1632 more authors) (2022) Search for gravitational waves associated with gamma-ray bursts detected by Fermi and Swift during the LIGO–Virgo run O3b. The Astrophysical Journal, 928 (2). 186. ISSN 0004-637X
Abbott, R, Abbott, TD, Acernese, F et al. (1624 more authors) (2022) Constraints on dark photon dark matter using data from LIGO’s and Virgo’s third observing run. Physical Review D, 105 (6). 063030. ISSN 2470-0010
Lin, C-Y, Wolf, J, Brice, DC et al. (20 more authors) (2022) Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response. Cell Host and Microbe, 30 (1). 83-96.e4. ISSN 1931-3128
Abbott, R, Abbott, TD, Abraham, S et al. (1596 more authors) (2021) Observation of gravitational waves from two neutron star–black hole coalescences. The Astrophysical Journal Letters, 915 (1). L5. ISSN 2041-8205
Conference or Workshop Item
Kavanaugh, A, Helliwell, P orcid.org/0000-0002-4155-9105, Sesin, C et al. (6 more authors) (2021) Low Disease Thresholds up to Three Years in Ixekizumab-Treated Patients with Psoriatic Arthritis in SPIRIT-P1 and SPIRIT-P2. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.